Medical devices: 5 tips for commercialization in China

For medical device companies, the Chinese market is an obvious and inviting target.Growth in China’s economy, in general, and its healthcare sector, in particular, has been well documented, but it’s worth taking a look at a few numbers again.var page_count = “off”; if (typeof OAS_rdl [...]

[Read more of this report]


Chinese medical device market to grow 17 percent in 2012

The Chinese medical device market is expected to grow 17 percent, according to Citigroup’s first hospital survey. Just 11 medical equipment segments are due to grow to $5 billion.That overall growth is based on a projection of 12 percent growth in the medical equipment market and 25 percent growth in medical consumables. Strong demand from [...]

[Read more of this report]


Quintiles launches new China CRO Kun Tuo

Quintiles is expanding its reach in the Asia-Pacific region with the launch of Kun Tuo, a new contract research organization in China.The new CRO will serve pharmaceutical companies in China as well as multinational biopharma companies that have operations in the country. Kun Tuo will also tap the resources of Durham, North Carolina-based Quintiles, which [...]

[Read more of this report]


Report: Global market for medical devices to reach $350 billion by 2016

Growth in developing countries and demand for cheaper, more efficient products will drive the value of the global medical device market to $350 billion by 2016, a new report predicts.Espicom Business Intelligence’s new analysis on the outlook for the medical device industry worldwide predicts the global market will grow 5 percent annually until 2016.It’s not [...]

[Read more of this report]


CHOP forms partnership with genomics center

The Children’s Hospital of Philadelphia has partnered with Beijing Genomics Institute, or BGI, the largest genomics institute in the world, to do large-scale human sequencing and bioinformatics analysis at the Joint Genome Center at the hospital.BGI@CHOP will focus on genes that underpin rare and common pediatric diseases using next-generation sequencing. CHOP has expertise in clinical [...]

[Read more of this report]


China, vaccines drive Merck performance

Merck (NYSE:MRK) posted net income of $1.6 billion in the third quarter, eclipsing its performance for the same time last year, aided by its cervical cancer vaccine and strong growth in China.Revenue for the Whitehouse Station, New Jersey pharmaceutical company for the quarter rose 8 percent to $12 billion. Sales of combination diabetes drug Janumet [...]

[Read more of this report]


Drexel launches research center with Shanghai-based institute

Drexel University in Philadelphia has signed an agreement with Shanghai Advanced Research Institute in a move to produce more collaboration between faculty and researchers at the institutions.John A. Fry, Drexel’s president, announced the launch of the Drexel-SARI center in Shanghai with the president of the Shanghai Advanced Research Institute, Dr. Feng Songlin.One of the first [...]

[Read more of this report]


Chinese venture capital firm adds Cleveland adviser

A Cleveland venture capitalist who co-founded Bridge Investment Fund has taken on a new role as a senior adviser to an early stage Chinese investment fund.Michael Goldberg will work with Kaiwu Capital, a China-based venture group, to help the fund identify market and collaboration opportunities for its portfolio companies — particularly in the biomedical industry [...]

[Read more of this report]


PPD names chief scientific officer for China subsidiary BioDuro

Clinical research organization PPD (NYSE:PPDI) has appointed a chief scientific officer for BioDuro, its drug discovery subsidiary in China.Jasmine Cui brings to PPD more than 15 years of drug discovery experience, including 14 years at Merck (NYSE:MRK). Wilmington, North Carolina-based PPD has made China a big part of its business through acquisitions. In 2009, the [...]

[Read more of this report]


Boston Scientific spends $150M to expand its Chinese operations

Boston Scientific Corp. (NYSE:BSX) sank $150 million into a five-year plan to expand Chinese commercial operations, including establishing a wholly owned manufacturing site and developing training centers for Chinese health care providers.The Natick, Mass.-based med-tech giant also plans to increase its Chinese workforce six-fold from 200 to more than 1,200 while investing further in R&D [...]

[Read more of this report]


Older Posts »

Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Twitter Buzz

MedCity Jobs Board

Real Time Web Analytics